About
Tamika Lang DMSc, MHS, PA-C Founder/CEO & Principal Consultant
Dr. Tamika Lang obtained her bachelor's in biology from Fairfield University in 2010, her master's in health sciences from Duke University School of Medicine Physician Assistant Program in 2014, and her doctorate in medical sciences with a focus on education in December 2022 from A.T. Still University. Dr. Lang is a licensed Physician Assistant (PA) and has previously worked clinically in inpatient internal medicine as a hospitalist PA at New York-Presbyterian/ Weill Cornell Medical Center in New York, NY, and as an inpatient and outpatient palliative medicine PA. She currently holds faculty appointments for PA and Doctor of Medical Science programs and works clinically in inpatient internal medicine as a Hospitalist in Greenville, SC. She also volunteers at a free medical clinic that provides primary care to uninsured patients in Clinton, SC.
From 2019 to 2021, Dr. Lang lived in Munich, Germany, where she worked as the Head of Research and Clinical Affairs for an umbrella myeloma patient advocacy organization. Since this time she has expanded her portfolio to include and developed patient engagement, educational, and research projects in various disease areas such as sickle cell anemia, chronic lymphocytic leukemia, myeloma, neuroendocrine tumors, and most notably educational projects that address the increasing maternal morbidity and mortality amongst the Black and Brown community in the United States. Dr. Lang continues to built relationships with the patient community and the pharmaceutical industry to promote patient engagement in clinical trials and other initiatives to raise the patient voice. She hopes to continue to use her unique perspectives and expertise in medicine, clinical experience, and advocacy knowledge to build international relationships with industry and patient advocacy organizations to improve advocacy, health literacy, and patient engagement.
Tamika Lang DMSc, MHS, PA-C Founder/CEO & Principal Consultant
Tamika Lang obtained her bachelor's in biology from Fairfield University in 2010 and her master's in health sciences from Duke University School of Medicine Physician Assistant Program in 2014. She is currently studying for her doctorate in medical sciences with a focus on education, with anticipated completion in December 2022. Tamika is a licensed Physician Assistant (PA) currently living in Greenville, South Carolina, and has previously worked clinically in inpatient internal medicine as a hospitalist PA at New York-Presbyterian/ Weill Cornell Medical Center in New York, NY, and as an inpatient and outpatient palliative medicine PA in Spartanburg, South Carolina.
From 2019 to 2021, Tamika lived in Munich, Germany, where she worked as the Head of Research and Clinical Affairs for an umbrella myeloma patient advocacy organization, Myeloma Patients Europe (MPE). At MPE, she developed a strong desire for patient advocacy initiatives and combined her unique expertise in medicine, clinical experience, and advocacy knowledge to provide educational and strategic support and to empower patient advocates. During this time, Tamika participated in multiple Horizon2020 European Union-funded projects and acted as the MPE project manager for the CARAMBA consortium conducting a CAR-T clinical trial in myeloma. Through this project, Tamika developed patient-centered research plans and strategies. Tamika also worked with the Innovative Medicine Initiative-Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (IMI-PREFER) study to design and develop standardized methods of patient preference study conduct. In addition to research projects, Tamika redefined MPE’s scientific and medical strategy. She built relationships with the patient community and the pharmaceutical industry to promote patient engagement in clinical trials and other initiatives to raise the patient voice. She hopes to continue to use her unique perspectives to build international relationships with industry and patient advocacy organizations to improve advocacy, health literacy, and patient engagement.
Tamika is married, has one daughter, and currently resides in South Carolina, USA.
Education
Publications
Joyner K, Galinsky J, Lang T, et al. The impact of SARS-CoV-2 (COVID-19) on the treatment of patients with myeloma and AL amyloidosis (poster). 18th IMW: International Myeloma Workshop annual congress. 2021
Janssens R, Lang T, Vallejo A, et al. Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study. Front Med (Lausanne). 2021;8:686165. Published 2021 Jul 6. doi:10.3389/fmed.2021.686165
Janssens R, Lang T, Vallejo A, et al. Developing Treatment Attributes for a Patient Preference Survey: A Qualitative Multinational Study in Multiple Myeloma (poster). EHA2021: European Hematology Association annual congress. 2021.
Janssens R, Lang T, Vallejo A, et al. What Matters Most to Multiple Myeloma Patients: A Patient Preference Study (poster). ISPOR: The Professional Society for Health Economics and Outcomes Research Virtual Congress. 2020.
Lang, T, Joyner K, Vallejo A. SARS-CoV-2 (COVID-19) Vaccination for Myeloma Patients. Munich, Germany. Myeloma Patients Europe. 2020. Published in several languages and used by the Macedonian Ministry of Health.
Lang, T. Myeloma and AL Amyloidosis Advocate Development Program Coursebook. Munich, Germany. Myeloma Patients Europe. 2020-2021.
Schempp A, Black WC, Lang T, et al. End of Curriculum Exam Version 1, forms 1 and 2. Washington, DC. Physician Assistant Education Association. 2021.
Lang T, Berkowitz O, Heistermann P. A comparison of German and United States physician assistant curricula. J Physician Assist Educ. 2022;33(1):66-71. doi:10.1097/JPA.0000000000000406
Heistermann P, Lang T, Heilmann C, Meyer-Treschan T. A brief introduction to PAs in Germany. JAAPA. 2022;35(6):52-55. doi:10.1097/01.JAA.0000830208.07114.a0
Heistermann P, …, Lang, T et al. A cross-sectional survey of German PA employment and workforce entry. JAAPA. 2022;35(12):45-49. doi:10.1097/01.JAA.0000892728.78698.75